Medical Week Daily

Medical news today: Thursday, November 5, 2026

FDA flags Vanda’s Nereus TV ad as misleading; Alnylam seeks new commercial chief amid Amvuttra miss; health systems block or buy doctor chatbots as use spreads (STAT+, paywall)

Get tomorrow's issue in your inbox.

  1. 01

    Alnylam seeks new commercial chief as Tanguler exits amid Amvuttra miss

    Source: Fierce Pharma

    Fierce Pharma reports Alnylam is seeking a new chief commercialization officer after Tolga Tanguler’s exit, with no reason given in the company announcement; the outlet links the change to weaker-than-expected Amvuttra sales that prompted guidance cuts and stock drops this year. Amvuttra is Alnylam’s RNA-interference therapy for transthyretin amyloidosis (ATTR).

    Why it mattersCommercial leadership changes at a company selling a key ATTR drug can affect patient support and access programs. Not investment advice. More on Approvals & regulatory →

    Market news · Not investment advice

  2. 02

    Health systems block or buy doctor chatbots as use spreads (STAT+, paywall)

    Source: STAT

    STAT reports hundreds of thousands of doctors use free clinician chatbots such as OpenEvidence, Doximity Ask and ChatGPT for Clinicians, which claim HIPAA compliance after users sign an agreement. Monument Health’s CIO said the South Dakota and Wyoming system blocked OpenEvidence after a doctor stored more than a hundred patient records in the tool for care decisions; some hospitals restrict access over compliance risks while others bring tools in house.

    Why it mattersHow hospitals treat these tools decides whether doctors keep pasting patient details into outside chatbots or use vetted systems that better protect health records.

  3. 03

    China tightens investigator-led biotech trials after patient deaths (STAT+, paywall)

    Source: STAT

    STAT reports that after deaths, news coverage and new government rules this summer, China has become far stricter on investigator-initiated trials (IITs), a pathway that let researchers start human tests without central regulator sign-off. Rare-disease families and foundations that used the faster, cheaper route say planned trials are now stalled, and US firms that relied on China IITs face an uncertain path.

    Why it mattersA clampdown on China’s fast IIT pathway can delay experimental options for rare-disease patients and change where biotech companies run early human studies. More on Approvals & regulatory →

  4. 04

    FDA flags Vanda’s fast-paced Nereus TV ad as misleading

    Source: Fierce Pharma

    Fierce Pharma reports the FDA’s Office of Prescription Drug Promotion issued an untitled letter over a Vanda TV ad for Nereus (tradipitant), approved to prevent motion-induced vomiting in adults. Regulators say the high-speed chase ad creates a misleading impression about timing and effectiveness and that fast-changing visuals interfere with required risk information; Vanda must respond.

    Why it mattersMisleading prescription ads can leave patients with the wrong idea about when a drug works and what risks to watch for. More on Approvals & regulatory →

  5. 05

    Midwives warn Norfolk maternity units may close

    Source: BBC Health

    BBC Health reports the Royal College of Midwives is concerned by reports that consultant-led maternity units at James Paget Hospital in Gorleston and/or the Queen Elizabeth Hospital in King's Lynn could close. The Norfolk and Waveney University Hospitals Group says its Case for Change options are a starting point, no decision has been made, and no consultation has begun.

    Why it mattersClosures could mean longer journeys in labour for women in Norfolk, Lowestoft, north Suffolk and north-east Cambridgeshire, and the union says neonatal and children's wards could close with them. Hospital leaders say any concentration of services would aim at safer care amid falling births and staffing shortages.

  6. 06

    FPME urges DCGI to ease export NOC delays

    Source: Pharmabiz

    Why it mattersDrug exporters want India’s drug regulator to cut delays in export no-objection certificates, which hold up shipments. More on Approvals & regulatory →

  7. 07

    India proposes instant licence suspension for makers of substandard drugs

    Source: The Hindu

    India's Health Ministry said on 4 November it has proposed changing the Drugs Rules, 1945 so regulators can immediately suspend a manufacturing licence when a government lab declares a drug "Not of Standard Quality" on strength, dissolution (how the drug releases), impurities or sterility. The suspension would last until the maker finds the root cause and fixes it to the regulator's satisfaction; today a show-cause notice comes first, so faulty batches can stay on sale meanwhile.

    Why it mattersIndia supplies medicines to much of the world, so faster action on failed batches could mean fewer substandard medicines reaching patients at home and abroad. More on Approvals & regulatory →

  8. 08

    Guinea-Bissau cancels US-funded hepatitis B vaccine trial on newborns

    Source: BBC Health

    A proposed trial of a hepatitis B vaccine in newborns in Guinea-Bissau has been cancelled after critics called it "unethical" and "neocolonial", the BBC reports. The US-funded study planned to involve 14,000 newborns and would have withheld a WHO-recommended birth dose from half of them; police have seized a batch of vaccines from the research centre.

    Why it mattersHepatitis B can pass from mother to baby at birth, and the row raises the question of whether families in poorer countries are being asked to accept research risks that would not be accepted in wealthier ones. More on Infectious disease →

  9. 09

    NHS leans more on charities, raising questions for patients

    Source: BBC Health

    BBC Health reports that the NHS is relying more on charities, and asks whether that is a sign of a health service at breaking point or a positive way of involving the public.

    Why it mattersThe BBC says the NHS's growing reliance on charities may be creating problems for patients, which bears on how care is funded and delivered.

  10. 10

    Brain firing patterns may flag Alzheimer's years before memory loss, Stanford study suggests

    Source: Medical Xpress

    Stanford Medicine-led researchers report that brain firing patterns in some cognitively normal adults foretold Alzheimer's disease years before memory loss or the build-up of plaques and tangles (the protein clumps linked to the disease). Other patterns pointed to brains unusually resistant to decline, on track for "super ager" status.

    Why it mattersAn earlier warning sign could one day give families more time to plan and let people start treatments or trials before damage sets in, though this is research, not a test you can get today. More on Neurology →

  11. 11

    Study finds little benefit from routine breast scans after double mastectomy for stage 0 cancer

    Source: Medical Xpress

    A UCLA Health-led study reports that women who had both breasts removed to treat ductal carcinoma in situ (DCIS, a non-invasive "stage 0" breast cancer) may not benefit from routine mammograms or other breast imaging afterwards.

    Why it mattersIf confirmed, it could spare some survivors repeated scans, worry and out-of-pocket imaging costs; decisions about follow-up still belong with each patient's care team. More on Oncology →

  12. 12

    Experts warn in The BMJ that fireworks are an underestimated public health danger

    Source: Medical Xpress

    US experts writing in The BMJ say fireworks pose an underestimated danger to public health and call for stronger regulation and sustained public education to prevent injuries they describe as devastating yet entirely avoidable.

    Why it mattersFireworks are part of festivals worldwide, and burns and eye injuries can bring lasting disability and large hospital bills for preventable accidents. More on Approvals & regulatory →

  13. 13

    Swapping dairy for unfortified plant milks may leave gaps in key nutrients, study warns

    Source: Medical Xpress

    A University of Surrey study reports that replacing dairy, even partly, with plant-based alternatives that are not fortified (have no added vitamins and minerals) may lead to deficiencies in vital nutrients, particularly iodine. The researchers say mandatory fortification of plant-based alternatives and foods such as bread could lessen the risk.

    Why it mattersMany households are switching to oat, almond or soy drinks, and the study suggests checking labels for added nutrients matters as much as the switch itself. More on Nutraceuticals & supplements →

  14. 14

    New US Congress may probe RFK Jr. and fix the surprise-billing law

    Source: MedPage Today

    MedPage Today reports that investigating Health Secretary Robert F. Kennedy Jr. and fixing the law on surprise medical bills (unexpected charges from out-of-network providers) may be on the agenda once the newly elected Congress sits.

    Why it mattersChanges to surprise-billing rules could affect how much US patients pay after emergency or hospital care, and US health policy often shapes drug and vaccine decisions worldwide. More on Infectious disease →

  15. 15

    Mobile clinics combining HIV prevention and addiction care cut deaths by 71% in US trial

    Source: Medical Xpress

    A clinical trial in five US cities found that offering HIV and substance-use treatment together in mobile medical units, with peer navigators (trained guides with lived experience), reduced deaths from any cause by 71% compared with referring people to community services alone. Researchers found no difference in use of daily oral PrEP, the HIV-prevention pill.

    Why it mattersBringing care to people where they are could save lives among groups who often miss clinic appointments, and the model may be copied by cities and health services elsewhere. More on Drug & device safety →

  16. 16

    Voters back abortion rights and transgender restrictions in some states

    Source: MedPage Today

    MedPage Today reports: (MedPage Today) -- Abortion-rights advocates notched victories in several states Tuesday, and voters in some states backed transgender restrictions as they decided 145 ballot questions in more than three dozen states. The ballot measures provided...

    Why it mattersMedPage Today says voters decided 145 ballot questions across more than three dozen states on Tuesday, results that will shape state health policy.

  17. 17

    Bernie Sanders gains major sway over the FDA funding bill (STAT+, paywall)

    Source: STAT

    STAT reports: Sanders could use his role in crafting the FDA funding bill to push for reforms.

    Why it mattersSTAT says Sanders could use his role in crafting the FDA funding bill to push for reforms, which could affect how the agency and drugmakers work. More on Approvals & regulatory →

  18. 18

    Women with longer lifetime estrogen exposure show fewer signs of brain small vessel disease

    Source: MedPage Today

    MedPage Today reports: (MedPage Today) -- Women with higher lifetime estrogen exposure had less cerebrovascular pathology, a cohort study in Sweden showed. A longer reproductive span was associated with 8% lower odds of having two or more signs of cerebral small vessel...

    Why it mattersIn a Swedish cohort, a longer reproductive span was linked with 8% lower odds of two or more signs of cerebral small vessel disease. It is an observational association, not proof of cause.

  19. 19

    CD38 immuno-PET finds myeloma lesions missed by standard scans

    Source: MedPage Today

    MedPage Today reports a phase II trial of a CD38-targeted zirconium-89 daratumumab PET/CT tracer found overall detection similar to standard FDG PET/CT (43% vs 47%), but each scan caught lesions the other missed: myeloma showed only on the new tracer in 13% of patients and only on FDG in 17%. The CD38 scan identified more disease sites in 28% of patients.

    Why it mattersStandard FDG PET can miss myeloma that takes up little glucose; a complementary scan could help doctors stage and treat disease more accurately. This is early trial evidence, not a change to routine care today. More on Obesity & metabolic →

  20. 20

    Cocaine overtakes heroin as top cause of drug deaths in England and Wales

    Source: BBC Health

    Cocaine was mentioned in 1,233 of the 5,519 drug poisoning deaths registered in England and Wales in 2025, edging past heroin or morphine (1,210), according to Office for National Statistics data reported by the BBC. Ketamine-linked deaths hit a record 115, while the overall drug death rate fell for the first time since 2012.

    Why it mattersCharities blame stronger, more available cocaine, a reminder that drug harms shift over time and that prevention and treatment services need to keep up. More on Drug & device safety →

  21. 21

    Nurix shares sell off as Sanofi drops partnered eczema drug

    Source: BioPharma Dive

    Sanofi has stopped developing an immune drug partnered with Nurix that was designed to break down a hard-to-target protein called STAT6, sparking a sell-off in Nurix shares and analyst debate about the whole drug class, BioPharma Dive reports.

    Why it mattersSTAT6 drugs were being studied for eczema, so the setback may delay a possible new pill option for patients and shows how one partner's decision can move a small biotech's value. Not investment advice. More on Pharma industry →

    Market news · Not investment advice

  22. 22

    CVS to split into two companies, separating Aetna and Caremark from its pharmacies

    Source: BioPharma Dive

    CVS plans to break into two companies, separating its Aetna insurance and Caremark pharmacy-benefit businesses from its retail pharmacies, BioPharma Dive reports, calling it a rebuke of the idea that bigger is always better in healthcare.

    Why it mattersCVS is one of America's biggest pharmacy and insurance groups, so the split could change how millions of people get prescriptions and coverage, and it may move healthcare stocks. Not investment advice. More on Markets →

    Market news · Not investment advice

  23. 23

    Analysts expect biopharma stocks to climb after Democrats' 'blue wave'

    Source: BioPharma Dive

    Analysts told BioPharma Dive that historical data suggests the drug sector outperforms after US midterm elections, and that Democrats, now in control of Congress, have "bigger fish to fry" than drug pricing.

    Why it mattersIf drug pricing slips down the agenda, US price relief for patients may come more slowly, while pharma jobs and pension funds holding drug stocks could benefit. Not investment advice. More on Markets →

    Market news · Not investment advice

  24. 24

    Weekly vitamin D (calcifediol) dose kept levels up in deficient women over a year, study reports

    Source: NutraIngredients

    A study in the journal Nutrients suggests weekly calcifediol (a form of vitamin D3) raised and maintained vitamin D levels over 12 months in women with vitamin D deficiency, both before and after menopause.

    Why it mattersVitamin D deficiency is common worldwide, and a once-a-week option may be easier to stick to; whether you need a supplement is a question for your doctor. More on Nutraceuticals & supplements →

  25. 25

    Japan study finds NMN supplements show inconclusive heart and brain benefits

    Source: NutraIngredients

    A study from Japan reported inconclusive benefits for heart-lung and cognitive function in healthy people who took NMN (nicotinamide mononucleotide, a popular "anti-ageing" supplement) alone or combined with ingredients such as berberine, CoQ10 and spermidine for 42 days.

    Why it mattersNMN products are sold at premium prices, so evidence that benefits are unclear helps shoppers weigh whether they are worth the money. More on Infectious disease →

New here? How to read this digest
Each story links to its original source. "Why it matters" explains what it means for you in plain language. This is news, not medical advice: talk to your doctor about your own care. Browse all topics or the archive.

More recent digests

Free daily email

The day's approvals, safety signals and trials, in five minutes.

Join the list with just your email. You can also follow the RSS feed.

Free, one field, no spam. We only use your address to send Medical Week Daily and never sell it. Ask to be removed any time via the contact page. See the privacy note.

For information and education only. Not medical advice. Medical Week Daily summarizes published health news in plain language for general readers. It does not replace advice from your doctor, product labeling or regulatory documents. Always consult a qualified healthcare professional about your own care, and check the original source. Full medical disclaimer